BeyondSpring Inc.
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has co…
Biotechnology
US, New York [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
BeyondSpring Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDBeyondSpring Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of BeyondSpring Inc..
If you want to see a demo, head over to the financial segments of AAPL